Clinical efficacy of piperacillin/tazobactam in the treatment of complicated skin and soft tissue infections.

about

Clinical efficacy of piperacillin/tazobactam in the treatment of complicated skin and soft tissue infections.

Item

http://www.wikidata.org/entity/Q39382608

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Clinical efficacy of piperacil ...... in and soft tissue infections.

@en

Clinical efficacy of piperacil ...... in and soft tissue infections.

@nl

type

Item

label

Clinical efficacy of piperacil ...... in and soft tissue infections.

@en

Clinical efficacy of piperacil ...... in and soft tissue infections.

@nl

prefLabel

Clinical efficacy of piperacil ...... in and soft tissue infections.

@en

Clinical efficacy of piperacil ...... in and soft tissue infections.

@nl

P1476

Clinical efficacy of piperacil ...... in and soft tissue infections.

@en

P2093

Daisuke Suzuki

http://www.w3.org/2001/XMLSchema#string

Kohei Takimoto

http://www.w3.org/2001/XMLSchema#string

Mitsuya Katayama

http://www.w3.org/2001/XMLSchema#string

Qianzhi Wang

http://www.w3.org/2001/XMLSchema#string

Yoshiro Hayashi

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections

A critical review of the fluoroquinolones: focus on respiratory infections

Epidemiology and Outcomes of Complicated Skin and Soft Tissue Infections among Inpatients in Southern China from 2008 to 2013

Ertapenem versus piperacillin/tazobactam for the treatment of complicated infections: a meta-analysis of randomized controlled trials

Trends in US hospital admissions for skin and soft tissue infections

Clinafloxacin versus piperacillin-tazobactam in treatment of patients with severe skin and soft tissue infections.

Penetration of piperacillin and tazobactam into inflamed soft tissue of patients with diabetic foot infection.

Risk factors for piperacillin-tazobactam-resistant Pseudomonas aeruginosa among hospitalized patients

Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.

Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America.

P304

1027-1034

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14656566.2017.1341491

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28627952

http://www.w3.org/2001/XMLSchema#string